Ubs Asset Management Americas Inc Xencor Inc Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Xencor Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 269,693 shares of XNCR stock, worth $5.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

269,693

Previous 269,342 0.13%

Holding current value

$5.02 Million

Previous $5.72 Million 4.37%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $6,546 - $9,308	351 Added 0.13%	269,693 $5.97 Million
Q4 2023 Feb 14, 2024	SELL	$16.53 - $21.42 $44,812 - $58,069	-2,711 Reduced 1.0%	269,342 $5.72 Million
Q3 2023 Nov 13, 2023	BUY	$20.08 - $25.39 $84,135 - $106,384	4,190 Added 1.56%	272,053 $5.48 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $10,302 - $14,669	397 Added 0.15%	267,863 $7.47 Million
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $430,676 - $536,130	17,373 Added 6.95%	267,466 $6.96 Million

Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $58,201 - $76,688	2,364 Added 0.95%	250,093 $6.5 Million
Q2 2022 Aug 12, 2022	SELL	$19.74 - $29.01 $351,391 - $516,407	-17,801 Reduced 6.7%	247,729 $6.78 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $90,738 - $141,583	-3,401 Reduced 1.26%	265,530 $7.08 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $221,178 - $285,357	-6,569 Reduced 2.38%	268,931 $10.8 Million
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $192,972 - $224,641	-6,296 Reduced 2.23%	275,500 $9 Million
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $2.07 Million - $2.7 Million	60,338 Added 27.25%	281,796 $9.72 Million
Q1 2021 May 14, 2021	SELL	$40.81 - $53.88 $111,533 - $147,254	-2,733 Reduced 1.22%	221,458 $9.54 Million
Q4 2020 Mar 01, 2021	SELL	$36.63 - $47.63 $417,362 - $542,696	-11,394 Reduced 4.84%	224,191 $9.78 Million
Q3 2020 Nov 13, 2020	BUY	$30.09 - $43.02 $221,462 - $316,627	7,360 Added 3.22%	235,585 $9.14 Million
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $343,946 - $414,073	12,390 Added 5.74%	228,225 $7.39 Million
Q1 2020 May 15, 2020	SELL	$20.69 - $37.79 $609,279 - $1.11 Million	-29,448 Reduced 12.01%	215,835 $6.45 Million
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $64,779 - $81,948	1,978 Added 0.81%	245,283 $8.44 Million
Q3 2019 Nov 14, 2019	BUY	$33.73 - $46.27 $121,056 - $166,063	3,589 Added 1.5%	243,305 $8.21 Million
Q2 2019 Aug 15, 2019	SELL	$29.6 - $40.93 $83,916 - $116,036	-2,835 Reduced 1.17%	239,716 $0
Q1 2019 May 14, 2019	BUY	$27.85 - $38.09 $1.76 Million - $2.4 Million	63,061 Added 35.13%	242,551 $0
Q4 2018 Feb 13, 2019	BUY	$32.39 - $42.05 $4.74 Million - $6.16 Million	146,385 Added 442.18%	179,490 $6.49 Million
Q2 2018 Aug 14, 2018	BUY	$28.41 - $42.41 $191,369 - $285,673	6,736 Added 25.55%	33,105 $0
Q1 2018 May 14, 2018	BUY	$21.18 - $33.78 $360,060 - $574,260	17,000 Added 181.45%	26,369 $0
Q4 2017 Feb 09, 2018	BUY	$19.29 - $24.83 $180,728 - $232,632	9,369	9,369 $0

Others Institutions Holding XNCR

# of Institutions

203

Shares Held

64M

Call Options Held

2.2K

Put Options Held

1.3K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.11B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Xencor Inc Transaction History